Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Swedish Orphan Biovitrum (BIOVF) had Revenue of $661.82M for the most recently reported fiscal quarter, ending 2024-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2024-09-30

Income Statement Financials
Revenue	$661.82M
Net Income	$140.54M
Cost of Goods Sold	$127.78M
Gross Profit	$534.05M
Operating Expenses	$466.08M
Operating Income	$195.74M
Non-Operating Income/Expense	$-31.30M
Pre-Tax Income	$164.35M
Normalized Pre-Tax Income	$164.35M
Income after Taxes	$140.54M
Income from Continuous Operations	$140.54M
Consolidated Net Income/Loss	$140.54M
Normalized Income after Taxes	$140.54M
EBIT	$195.74M
EBITDA	$289.09M
Weighted-Average Shares Outstanding (Basic)	343.01M
Weighted-Average Shares Outstanding (Diluted)	346.84M
Earnings per Share (EPS) (Basic)	$0.41
Earnings per Share (EPS) (Diluted)	$0.41
Balance Sheet Financials
Current Assets	$1.21B
Property, Plant, and Equipment	$36.86M
Long-Term Assets	$5.72B
Total Assets	$6.93B
Current Liabilities	$1.33B
Long-Term Debt	$1.10B
Long-Term Liabilities	$2.03B
Total Liabilities	$3.37B
Common Equity	$3.56B
Tangible Shareholders Equity	$-1.99B
Shareholders Equity	$3.56B
Common Shares Outstanding	343.44M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$536.74M
Cash Flow from Investing Activities	$-287.04M
Cash Flow from Financial Activities	$-273.70M
Beginning Cash	$86.78M
End Cash	$57.02M
Increase/Decrease in Cash	$-29.76M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.91
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.24
Debt to Equity Ratio	0.31
Gross Margin	80.69%
Operating Margin	29.58%
EBIT Margin	29.58%
EBITDA Margin	--
Pre-Tax Profit Margin	24.83%
Profit Margin	21.24%
Free Cash Flow	$529.54M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.33
Receiveable Turnover	0.86
Days Sales in Receivables	105.21
Return on Equity	3.95%
Return on Tangible Equity	-7.05%
Return on Assets	2.03%
Return on Investments	3.01%
Book Value Per Share	$10.37
Free Cash Flow per Share	$1.53
Operating Cash Flow per Share	$1.55

Data from Zacks Investment Research, Inc.